Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

BACKGROUND: Several studies have demonstrated that long-acting β(2)-agonists such as salmeterol are beneficial in chronic obstructive pulmonary disease (COPD). A meta-analysis was therefore conducted to review studies in COPD to provide pooled estimates of the effect of salmeterol 50 mcg taken twice...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockley, Robert A, Whitehead, Philip J, Williams, Michael K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779294/
https://www.ncbi.nlm.nih.gov/pubmed/17196106
http://dx.doi.org/10.1186/1465-9921-7-147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779294/
https://www.ncbi.nlm.nih.gov/pubmed/17196106
http://dx.doi.org/10.1186/1465-9921-7-147

Ejemplares similares